CIK 0001728117 · Non-accelerated filer<br>Smaller reporting company
Gossamer Bio, Inc.
Sign in to watch- Ticker
- GOSS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475461709
- Phone
- (858) 684-1300
- Business address
- 3115 MERRYFIELD ROW, SUITE 120, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 6 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-14 | Salter-Cid Luisa Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +71,500 | 71,500 | ||
| 2020-02-14 | Christian Waage EVP & General Counsel | Grant or award | +46,500 | 547,998 | ||
| 2020-02-14 | Christian Waage EVP & General Counsel | Grant or award · Stock Option (right to buy) | +71,500 | 71,500 | ||
| 2020-02-14 | Giraudo Bryan Chief Financial Officer | Grant or award | +46,500 | 70,379 | ||
| 2020-02-14 | Giraudo Bryan Chief Financial Officer | Grant or award · Stock Option (right to buy) | +71,500 | 71,500 | ||
| 2020-02-14 | Gujrathi Sheila President & CEO | Grant or award | +189,500 | 189,500 | ||
| 2020-02-14 | Gujrathi Sheila President & CEO | Grant or award · Stock Option (right to buy) | +292,000 | 292,000 | ||
| 2019-12-31 | Salter-Cid Luisa Chief Scientific Officer | Gift | −4,000 | 120,056 | ||
| 2019-12-30 | Dupont Jakob Chief Medical Officer | Option exercise | +40,000 | $10.71 | $428K | 40,000 |
| 2019-12-30 | Dupont Jakob Chief Medical Officer | Sale | −40,000 | $15.00 | $600K | 0 |
| 2019-12-30 | Dupont Jakob Chief Medical Officer | Option exercise · Non-qualified stock option (Right to Buy) | −40,000 | 439,317 | ||
| 2019-12-27 | Dupont Jakob Chief Medical Officer | Option exercise | +1,994 | $10.71 | $21K | 1,994 |
| 2019-12-27 | Dupont Jakob Chief Medical Officer | Sale | −1,994 | $15.81 | $32K | 0 |
| 2019-12-27 | Dupont Jakob Chief Medical Officer | Option exercise · Non-qualified stock option (Right to Buy) | −1,994 | 479,317 | ||
| 2019-09-27 | Christian Waage EVP & General Counsel | Purchase | +1,000 | $16.65 | $17K | 4,454 |
| 2019-09-27 | Hasnain Faheem Director | Purchase | +10,000 | $16.80 | $168K | 3,382,109 |
| 2019-09-27 | Gujrathi Sheila President & CEO | Purchase | +10,000 | $16.80 | $168K | 4,048,242 |
| 2019-09-26 | Giraudo Bryan Chief Financial Officer | Purchase | +1,121 | $16.78 | $19K | 2,121 |
| 2019-09-20 | Omega Fund V, L.P. 10% owner | Sale | −183,607 | $21.96 | $4.0M | 6,553,416 |
| 2019-09-18 | Omega Fund V, L.P. 10% owner | Sale | −45,600 | $21.88 | $998K | 6,737,023 |
Page 18 of 21 · 401 trades